TerminatedNot Applicable

Measurement of in Vivo Mitochondrial Capacity in Infants

Stopped: Decoupler equipment used for 31P magnetic resonance is being serviced

United States2 participantsStarted 2019-05-21

Plain-language summary

The overarching aim of this project is to determine the test re-test reliability of 31P-magnetic resonance spectroscopy measurements in infants. Primary endpoints include two separate measures of in vivo mitochondrial capacity (ATPmax) over a 1-10 day period to assess feasibility and reliability.

Who can participate

Age range14 Days – 28 Days

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * healthy, full-term infant * aged 14-28 days at Visit 1 * willingness of parents to be notified of incidental findings from study procedures Exclusion Criteria: * born preterm * implanted metal or electronic objects that render MRI unsafe * unable to complete 2 clinic visits 1-10 days apart at Pennington Biomedical Research Center

What they're measuring

In vivo mitochondrial capacity (ATPmax)

Timeframe: 1 day

Trial details

NCT IDNCT03976596

SponsorPennington Biomedical Research Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-07-02

View on ClinicalTrials.gov More Healthy Infants trials